• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期乳腺癌内分泌治疗中雌激素受体定量评估的意义

Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer.

作者信息

Heuson J C, Longeval E, Mattheiem W H, Deboel M C, Sylvester R J, Leclercq G

出版信息

Cancer. 1977 May;39(5):1971-7. doi: 10.1002/1097-0142(197705)39:5<1971::aid-cncr2820390510>3.0.co;2-8.

DOI:10.1002/1097-0142(197705)39:5<1971::aid-cncr2820390510>3.0.co;2-8
PMID:870163
Abstract

The predictive significance of quantitative assessment of estrogen receptors in tumor tissue was analyzed in women with advanced breast carcinoma. Receptor concentration was measured by the 3H-estradiol binding capacity of the cytosol fraction of biopsies taken before initiation of the treatment. The E. O. R. T. C. criteria for the assessment of the patients' response were used. In a total of 34 assessments, 25 biopsies contained receptors; the remaining ones were negative. Objective remission to various endocrine therapies was recorded in only eight of the receptor-positive patients. Responses occurred along the whole scale of receptor concentrations with an apparent crowding in the region of the higher values. Linear logistic regression analysis revealed that among 12 variables of known prognostic value, receptor concentration was the most significant in relation to therapeutic response. Other significant variables were bone involvement and age. Computations yielded formulas that are presented in graph form and provide an estimate of the probability of a given patient to respond to endocrine treatments. On the other hand, the results suggest that all patients are possibly hormone dependent, although to variable degrees. The latter concept has very definite therapeutic implications.

摘要

对晚期乳腺癌女性患者肿瘤组织中雌激素受体定量评估的预测意义进行了分析。通过治疗开始前活检的细胞溶质部分的3H-雌二醇结合能力来测量受体浓度。采用欧洲癌症研究与治疗组织(E.O.R.T.C.)评估患者反应的标准。在总共34次评估中,25份活检样本含有受体;其余样本为阴性。仅8名受体阳性患者记录到对各种内分泌治疗的客观缓解。反应出现在受体浓度的整个范围内,在较高值区域明显聚集。线性逻辑回归分析显示,在12个已知预后价值的变量中,受体浓度与治疗反应的关系最为显著。其他显著变量是骨转移和年龄。计算得出以图表形式呈现的公式,可估计给定患者对内分泌治疗反应的概率。另一方面,结果表明所有患者可能都有激素依赖性,尽管程度不同。后一概念具有非常明确的治疗意义。

相似文献

1
Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer.晚期乳腺癌内分泌治疗中雌激素受体定量评估的意义
Cancer. 1977 May;39(5):1971-7. doi: 10.1002/1097-0142(197705)39:5<1971::aid-cncr2820390510>3.0.co;2-8.
2
Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.晚期乳腺癌中雌激素受体定量评估的临床意义
Cancer. 1980 Dec 15;46(12 Suppl):2889-95. doi: 10.1002/1097-0142(19801215)46:12+<2889::aid-cncr2820461430>3.0.co;2-4.
3
Proceedings: Clinical value of predictive tests for advanced breast cancer.会议论文:晚期乳腺癌预测性检测的临床价值
Br J Cancer. 1974 Aug;30(2):189-90. doi: 10.1038/bjc.1974.178.
4
Human breast cancer and estrogen receptor.人类乳腺癌与雌激素受体
Arch Chir Neerl. 1973;25(4):393-7.
5
The prediction of hormonal dependency of mammary cancer.乳腺癌激素依赖性的预测。
Ann Surg. 1975 Sep;182(3):342-52. doi: 10.1097/00000658-197509000-00017.
6
Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer.萘福昔定用于肾上腺切除术后晚期乳腺癌患者的临床试验。
Cancer. 1977 Nov;40(5):2063-6. doi: 10.1002/1097-0142(197711)40:5<2063::aid-cncr2820400511>3.0.co;2-w.
7
Antiestrogens in treatment of breast cancer.抗雌激素药物在乳腺癌治疗中的应用
Cancer. 1977 Jun;39(6 Suppl):2959-64. doi: 10.1002/1097-0142(197706)39:6<2959::aid-cncr2820390682>3.0.co;2-2.
8
[Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)].
Arch Geschwulstforsch. 1981;51(7):623-9.
9
3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy.在内分泌治疗前及治疗期间,通过针吸获取的乳腺癌细胞中3H-胸腺嘧啶核苷的掺入情况。
Acta Cytol. 1976 Mar-Apr;20(2):137-43.
10
Estrogen receptors in hormone-dependent breast cancers.激素依赖性乳腺癌中的雌激素受体
Cancer Res. 1975 Nov;35(11 Pt. 2):3362-4.

引用本文的文献

1
Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer.高 ER 负荷与 1-3 期乳腺癌的更好结局无关:可手术乳腺癌中定量 HR 分析的描述性概述。
Breast Cancer Res Treat. 2019 Jul;176(1):27-36. doi: 10.1007/s10549-019-05233-9. Epub 2019 Apr 17.
2
Molecular Diagnostics in Clinical Oncology.临床肿瘤学中的分子诊断
Front Mol Biosci. 2018 Aug 27;5:76. doi: 10.3389/fmolb.2018.00076. eCollection 2018.
3
Clinical applications of receptor measurements in breast cancer.
受体测量在乳腺癌中的临床应用
Br J Cancer. 1980 Jan;41(1):136-9. doi: 10.1038/bjc.1980.16.
4
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.
5
Relationship between ER-ICA and conventional steroid receptor assays in human breast cancer.
Breast Cancer Res Treat. 1986;8(1):35-43. doi: 10.1007/BF01805923.
6
Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.原发性乳腺癌的组织学分级和类固醇受体含量——对预后的影响及可能的作用方式
Br J Cancer. 1988 Oct;58(4):480-6. doi: 10.1038/bjc.1988.245.
7
Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.原发性乳腺癌中雌激素受体的测定。生化葡聚糖包被活性炭法与免疫组织学技术的比较。
J Cancer Res Clin Oncol. 1988;114(6):623-7. doi: 10.1007/BF00398188.
8
Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.波形蛋白在雌激素受体低且Ki-67生长分数高的人类乳腺癌中优先表达。
Am J Pathol. 1990 Jan;136(1):219-27.
9
Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment.原发性乳腺癌中雌激素受体含量与最终内分泌治疗的相关性。
Ann Surg. 1978 Sep;188(3):372-6. doi: 10.1097/00000658-197809000-00012.
10
Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features.
Cancer Chemother Pharmacol. 1979;2(2):115-20. doi: 10.1007/BF00254083.